The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Momenta Pharmaceuticals Inc

Nasdaq: MNTA
Last

(U.S.) $15.10

Today's change0.00 0.00%
Updated February 22 4:00 PM EST. Delayed by at least 15 minutes.
 

Momenta Pharmaceuticals Inc

Nasdaq: MNTA
Last

(U.S.) $15.10

Today's change0.00 0.00%
Updated February 22 4:00 PM EST. Delayed by at least 15 minutes.

Momenta Pharmaceuticals Inc closed at (U.S.)$15.10.

Shares have lost 20.73% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 25.01% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $15.10
  • High--
  • Low--
  • Bid / Ask(U.S.) $15.05 / (U.S.) $15.60
  • YTD % change+0.33%
  • Volume0
  • Average volume (10-day)976,451
  • Average volume (1-month)813,668
  • Average volume (3-month)660,088
  • 52-week range(U.S.) $7.86 to (U.S.) $19.90
  • Beta1.75
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.31
Updated February 22 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue29262022
Total other revenue--------
Total revenue29262022
Gross profit--------
Total cost of revenue--------
Total operating expense47484452
Selling / general / administrative16151614
Research & development32332938
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-18-22-25-30
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-18-21-24-29
Income after tax-18-21-24-29
Income tax, total--------
Net income-18-21-24-29
Total adjustments to net income--------
Net income before extra. items-18-21-24-29
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-18-21-24-29
Inc. avail. to common incl. extra. items-18-21-24-29
Diluted net income-18-21-24-29
Dilution adjustment----0--
Diluted weighted average shares69696868
Diluted EPS excluding extraordinary itemsvalue per share-0.26-0.31-0.35-0.43
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.26-0.31-0.35-0.43